📢 Latest Update: Is the UGC CARE List Still Valid in 2026? New Guidelines for Selecting Peer-Reviewed Journals View Now

International Journal of Cell Biology and Cellular Functions Cover

International Journal of Cell Biology and Cellular Functions

E-ISSN: 3139-1834 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access

About the Journal

International Journal of Cell Biology and Cellular Functions is a peer-reviewed hybrid open-access journal launched in 2023 that aims to stimulate the scientifically grounded exchange of ideas. It contains timely reviews and original research articles, with emphasis on cellular processes and cell biology, … including all major fields of research.

View full focus & scope More

Journal Information

Title: International Journal of Cell Biology and Cellular Functions
Abbreviation: ijcbcf
Issues Per Year: 2 Issues
E-ISSN: 3139-1834
Publisher: STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd.
DOI: 10.37591/IJCBCF
Starting Year: 2023
Subject: Cell Biology and Cellular Functions
Publication Format: Hybrid Open Access
Language: English
Copyright Policy: CC BY-NC-ND
Type: Peer-reviewed Journal (Refereed Journal)

Address:

STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd. A-118, 1st Floor, Sector-63, Noida, U.P. India, Pin - 201301

Editorial Board

View Full Editorial Board

ijcbcf maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Nasir Mukhtar, Scientist

PMAS Arid Agriculture University, Rawalpindi, Pakistan,

Email :

Latest Articles

Ahead of Print

The Redox Rheostat: A Review on Targeting the Oxidative Stress-to- Cell Death Continuum for Therapeutic Gain

For a long time, oxidative stress was cast as a plain villain, something to be pushed down with antioxidants wherever it appeared. That view has changed. Reactive oxygen species (ROS) do real work in the cell.

reactive oxygen species, redox signaling, oxidative stress, redox rheostat, stress

The Cellular Architecture of Feed Efficiency: Can Single-Cell Multi-Omics, Spatial Metabolomics, and Nutrient-Flux Mapping Reveal Hidden Metabolic Specialization across Intestinal, Hepatic, and Skeletal-Muscle Cell Populations in Poultry?

Feed efficiency in poultry emerges from complex interactions among nutrient absorption, metabolic transformation, cellular energy expenditure, and productive tissue accretion.

Feed efficiency; Cellular metabolic specialization; Single-cell multi-omics; Spatial metabolomics; Nutrient-flux mapping.

Unveiling Therapeutic Targets in COPD: A Synergistic Approach Using Network Pharmacology and Molecular Docking

COPD is a chronic lung disease that affects a large number of people worldwide and is a cause of death.

COPD, Zataria multiflora, network pharmacology, molecular docking, inflammation, Gene ontology, KEGG pathways

Sequence analysis, DNA Methylation and Molecular therapy of Oral cancer caused by Human Papilloma Virus

DNA methylations with oral cancer are been associated with high-risk Human Papillomavirus (HPV) and Epstein-Barr Virus (EBV) onco-proteins interactions may cooperate to increase disease severity.

DNA methylation, HPV16 strain, oral cancer

Mass Spectrometry–Based Phosphoproteomic Markers to Predict Kinase Inhibitor Response in Solid Tumors

Mass spectrometry-based phosphoproteomics has emerged as a powerful tool for predicting kinase inhibitor responses in solid tumors, offering direct functional insights into signaling pathways that surpass traditional genomic profiling by capturing dynamic kinase activities and adaptive resistance mechanisms.

Mass spectrometry, BRAF/MEK inhibitors, clinical translation, EGFR inhibitors, kinase inhibitors, liquid biopsy, machine learning, multiomic integration, phosphoproteomic biomarkers, phosphoproteomics, precision oncology, predictive biomarkers, resistance mechanisms, signaltransduction pathways, solid tumors.

Mass Spectrometry–Based Phosphoproteomic Markers to Predict Kinase Inhibitor Response in Solid Tumors

Mass spectrometry-based phosphoproteomics has emerged as a powerful tool for predicting kinase inhibitor responses in solid tumors, offering direct functional insights into signaling pathways that surpass traditional genomic profiling by capturing dynamic kinase activities and adaptive resistance mechanisms.

Mass spectrometry, BRAF/MEK inhibitors, clinical translation, EGFR inhibitors, kinase inhibitors, liquid biopsy, machine learning, multi-omic integration, phosphoproteomic biomarkers, phosphoproteomics, precision oncology, predictive biomarkers, resistance mechanisms, signal-transduction pathways, solid tumors
Support